Carmen Ruiz Velasco
Carmen Ruiz Velasco
Verified email at
Cited by
Cited by
Osteoprotegerin: multiple partners for multiple functions
M Baud’huin, L Duplomb, S Teletchea, F Lamoureux, C Ruiz-Velasco, ...
Cytokine & growth factor reviews 24 (5), 401-409, 2013
New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?
SK Tat, JP Pelletier, CR Velasco, M Padrines, J Martel-Pelletier
The Keio journal of medicine 58 (1), 29-40, 2009
Key roles of the OPG–RANK–RANKL system in bone oncology
M Baud’huin, L Duplomb, CR Velasco, Y Fortun, D Heymann, M Padrines
Expert review of anticancer therapy 7 (2), 221-232, 2007
Optical quantification of cellular mass, volume, and density of circulating tumor cells identified in an ovarian cancer patient
KG Phillips, CR Velasco, J Li, A Kolatkar, M Luttgen, K Bethel, B Duggan, ...
Frontiers in oncology 2, 72, 2012
Proteases and bone remodelling
S Georges, CR Velasco, V Trichet, Y Fortun, D Heymann, M Padrines
Cytokine & growth factor reviews 20 (1), 29-41, 2009
Multiplex protein detection on circulating tumor cells from liquid biopsies using imaging mass cytometry
E Gerdtsson, M Pore, JA Thiele, AS Gerdtsson, PD Malihi, R Nevarez, ...
Convergent science physical oncology 4 (1), 015002, 2018
Single-cell circulating tumor cell analysis reveals genomic instability as a distinctive feature of aggressive prostate cancer
PD Malihi, RP Graf, A Rodriguez, N Ramesh, J Lee, R Sutton, R Jiles, ...
Clinical Cancer Research 26 (15), 4143-4153, 2020
Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients
C Ruiz, J Li, MS Luttgen, A Kolatkar, JT Kendall, E Flores, Z Topp, ...
Physical biology 12 (1), 016008, 2015
Anti-metastatic properties of a marine bacterial exopolysaccharide-based derivative designed to mimic glycosaminoglycans
D Heymann, C Ruiz-Velasco, J Chesneau, J Ratiskol, C Sinquin, ...
Molecules 21 (3), 309, 2016
Effects of a sulfated exopolysaccharide produced by Altermonas infernus on bone biology
C Ruiz Velasco, M Baud'Huin, C Sinquin, M Maillasson, D Heymann, ...
Glycobiology 21 (6), 781-795, 2011
Treatment response and tumor evolution: lessons from an extended series of multianalyte liquid biopsies in a metastatic breast cancer patient
L Welter, L Xu, D McKinley, AE Dago, RK Prabakar, S Restrepo-Vassalli, ...
Molecular Case Studies 6 (6), a005819, 2020
Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: role in osteoclastogenesis and bone resorption
M Baud’Huin, C Ruiz-Velasco, G Jego, C Charrier, N Gasiunas, ...
European Journal of Cell Biology 90 (1), 49-57, 2011
Large extracellular vesicle characterization and association with circulating tumor cells in metastatic castrate resistant prostate cancer
AS Gerdtsson, SM Setayesh, PD Malihi, C Ruiz, A Carlsson, R Nevarez, ...
Cancers 13 (5), 1056, 2021
Clonal diversity revealed by morphoproteomic and copy number profiles of single prostate cancer cells at diagnosis
PD Malihi, M Morikado, L Welter, ST Liu, ET Miller, RM Cadaneanu, ...
Convergent science physical oncology 4 (1), 015003, 2018
Proteoglycans on bone tumor development
CR Velasco, S Colliec-Jouault, F Redini, D Heymann, M Padrines
Drug discovery today 15 (13-14), 553-560, 2010
Platelet-coated circulating tumor cells are a predictive biomarker in patients with metastatic castrate-resistant prostate cancer
S Chai, N Matsumoto, R Storgard, CC Peng, A Aparicio, B Ormseth, ...
Molecular Cancer Research 19 (12), 2036-2045, 2021
Preanalytical variables for the genomic assessment of the cellular and acellular fractions of the liquid biopsy in a cohort of breast cancer patients
SN Shishido, L Welter, M Rodriguez-Lee, A Kolatkar, L Xu, C Ruiz, ...
The Journal of Molecular Diagnostics 22 (3), 319-337, 2020
Bone cancer: progression and therapeutic approaches
D Heymann
Academic Press, 2009
Phase Ib study of enzalutamide with or without sorafenib in patients with advanced hepatocellular carcinoma
JJ Harding, RK Kelley, B Tan, M Capanu, GK Do, J Shia, JF Chou, ...
The oncologist 25 (12), e1825-e1836, 2020
Novel anti-cancer strategy in bone tumors by targeting molecular and cellular modulators of bone resorption.
B Brounais, C Ruiz, J Rousseau, F Lamoureux, F Blanchard, D Heymann, ...
Recent Patents on Anti-Cancer Drug Discovery 3 (3), 178-186, 2008
The system can't perform the operation now. Try again later.
Articles 1–20